C. Lemere

D. Selkoe, T. Wisniewski, C. Lemere, 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society

P. D. De Deyn, C. Lemere, M. Dierssen, 2018, Molecular Syndromology.

Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice

D. Walsh, C. Lemere, J. Dodart, 2015, Neurobiology of Disease.

Amyloid- β Immunotherapy for Alzheimer's Disease CNS Neurol Disord Drug Targets

C. Lemere, J. Frost, B. Liu, 2010 .

Novel Aβ Immunogens: Is Shorter Better?

C. Lemere, Marcel Maier, T. Seabrook, 2007 .

Species-specific immune response to immunization with human versus rodent Aβ peptide

D. Walsh, C. Lemere, M. Iglesias, 2004, Neurobiology of Aging.

Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice.

D. Holtzman, D. Selkoe, C. Lemere, 2003, Neurobiology of disease.

Mechanistic Studies of the Effect of Presenilins 1 and 2 on APP Metabolism

D. Selkoe, C. Lemere, M. Citron, 1998 .

Nasal Aβ Treatment Induces Anti‐Aβ Antibody Production and Decreases Cerebral Amyloid Burden in PD‐APP Mice

D. Selkoe, H. Weiner, C. Lemere, 2000 .

The AMY antigen co-occurs with abeta and follows its deposition in the amyloid plaques of Alzheimer's disease and down syndrome.

D. Selkoe, C. Lemere, T. J. Grenfell, 1999, The American journal of pathology.

The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.

Markus Glatzel, Zhiping Weng, Hans Lassmann, 2017, Immunity.

Traumatic Brain Injury in Aged Mice Induces Chronic Microglia Activation, Synapse Loss, and Complement-Dependent Memory Deficits

C. Lemere, M. Chaumeil, Brice Tiret, 2018, International journal of molecular sciences.

Intranasal immunotherapy for the treatment of Alzheimer’s disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants

C. Lemere, J. Clements, E. Spooner, 2002, Neurobiology of Aging.

Nasal Vaccination with β-Amyloid Peptide for the Treatment of Alzheimer's Disease

D. Selkoe, H. Weiner, C. Lemere, 2001 .

Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice.

Richard D. Kim, C. Lemere, Jie Shen, 2004, The Journal of biological chemistry.

Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.

D. Selkoe, T. Wisniewski, C. Lemere, 2000, The American journal of pathology.

Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 mice.

C. Lemere, M. Iglesias, E. Spooner, 2004, Vaccine.

Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II

K. Imahori, C. Lemere, A. Takashima, 1996, Acta Neuropathologica.

Deposition of phosphorylated amyloid‐β in brains of aged nonhuman primates and canines

C. Cotman, R. Palmour, C. Lemere, 2018, Brain pathology.

Boosting with intranasal dendrimeric Aβ1–15 but not Aβ1–15 peptide leads to an effective immune response following a single injection of Aβ1–40/42 in APP-tg mice

C. Lemere, T. Seabrook, Liying Jiang, 2006, Journal of Neuroinflammation.

Developing Novel Immunogens for an Effective, Safe Alzheimer’s Disease Vaccine

C. Lemere, Marcel Maier, T. Seabrook, 2006, Neurodegenerative Diseases.

Abeta1-15 is less immunogenic than Abeta1-40/42 for intranasal immunization of wild-type mice but may be effective for "boosting".

C. Lemere, J. Clements, E. Spooner, 2003, Vaccine.

The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol.

C. Lemere, E. Spooner, Jodi F. Leverone, 2002, Vaccine.

Characterization of Aβ11-40/42 peptide deposition in Alzheimer’s disease and young Down’s syndrome brains: implication of N-terminally truncated Aβ species in the pathogenesis of Alzheimer’s disease

J. Trojanowski, V. Lee, M. Mercken, 2006, Acta Neuropathologica.

Nasal Aβ immunization reduces amyloid-β protein burden in PDAPP mice

D. Selkoe, C. Lemere, E. Spooner, 2000, Neurobiology of Aging.

Active Amyloid-β Vaccination Results in Epigenetic Changes in the Hippocampus of an Alzheimer's Disease-Like Mouse Model.

B. Liu, C. Lemere, B. Rutten, 2019, Current Alzheimer research.

Localization of flotillins in human brain and their accumulation with the progression of Alzheimer's disease pathology

C. Lemere, H. Yamaguchi, Hideko Kokubo, 2000, Neuroscience Letters.

Acute Effects of Focused Ultrasound-Induced Blood-Brain Barrier Opening on Anti-Pyroglu3 Abeta Antibody Delivery and Immune Responses

N. McDannold, C. Lemere, S. Schilling, 2022, Biomolecules.

Immunotherapeutics for Neurological Disorders

C. Lemere, A. Messer, K. Manley, 2014 .

Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation.

A. Ruiz-Linares, A. Goate, J. Norton, 1997, JAMA.

BrightFocus Alzheimer’s Fast Track 2019

C. Lemere, F. LaFerla, H. Steinbusch, 2019, Molecular Neurodegeneration.

Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo

W. K. Cullen, R. Anwyl, M. Rowan, 2005, Nature Medicine.

Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

W. K. Cullen, R. Anwyl, M. Rowan, 2005, Nature medicine.

APP processing is regulated by cytoplasmic phosphorylation

L. Tsai, R. Neve, C. Lemere, 2003, The Journal of cell biology.

Novel Therapeutic Approach for the Treatment of Alzheimer's Disease by Peripheral Administration of Agents with an Affinity to β-Amyloid

C. Lemere, Y. Matsuoka, Vicki Olm, 2003, The Journal of Neuroscience.

De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease.

D. Walsh, C. Lemere, C. Vanderburg, 2013, Human molecular genetics.

l-3-n-Butylphthalide Improves Cognitive Impairment and Reduces Amyloid-β in a Transgenic Model of Alzheimer's Disease

Xiaoliang Wang, C. Lemere, W. Xia, 2010, The Journal of Neuroscience.

Effects of huperzine A on amyloid precursor protein processing and β‐amyloid generation in human embryonic kidney 293 APP Swedish mutant cells

S. Schachter, C. Lemere, Liying Jiang, 2006, Journal of neuroscience research.

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease

J. Yesavage, A. Fagan, D. Holtzman, 2009, Proceedings of the National Academy of Sciences.

Complement and microglia mediate early synapse loss in Alzheimer mouse models

Ben A. Barres, Beth Stevens, D. Selkoe, 2016, Science.

The epigenetics of aging and neurodegeneration

P. Hof, H. Steinbusch, D. Mastroeni, 2015, Progress in Neurobiology.

The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway

D. Selkoe, L. Lannfelt, C. Lemere, 1995, Nature Medicine.

Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease

C. Lemere, H. Sokol, G. Dorothée, 2022, Molecular neurodegeneration.

A Novel Gene in the Armadillo Family Interacts with Presenilin 1

K. Kosik, C. Lemere, M. Medina, 1998 .

Reduced β-Amyloid Production and Increased Inflammatory Responses in Presenilin Conditional Knock-out Mice*

Richard D. Kim, C. Lemere, Jie Shen, 2004, Journal of Biological Chemistry.

Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice

Beth Stevens, C. Lemere, B. Stevens, 2017, Science Translational Medicine.

Down syndrome and Alzheimer's disease: Common pathways, common goals

M. Carrillo, A. Granholm, M. Krams, 2015, Alzheimer's & Dementia.

Minocycline affects microglia activation, Aβ deposition, and behavior in APP‐tg mice

C. Lemere, Marcel Maier, T. Seabrook, 2006, Glia.

Clinical Features of Early-Onset Alzheimer Disease in a Large Kindred With an E280A Presenilin-1 Mutation

A. Ruiz-Linares, A. Goate, K. Kosik, 1997 .

Osteopetrotic (op/op) mice have reduced microglia, no Aβ deposition, and no changes in dopaminergic neurons

C. Lemere, T. Seabrook, Y. Kondo, 2007, Journal of Neuroinflammation.

Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

C. Lemere, M. O’Banion, Y. Matsuoka, 2001, The American journal of pathology.

Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer’s Disease

C. Lemere, M. Brito, C. Janota, 2015, Molecular Neurobiology.

Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline

Shaomin Li, Beth Stevens, Shaomin Li, 2015, The Journal of Neuroscience.

Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

C. Lemere, D. Wilcock, E. Head, 2015, Current Alzheimer research.

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

C. Lemere, H. Cynis, J. Frost, 2016, Molecular Neurodegeneration.

R. Palmour, C. Lemere, B. Rutten, 2018, Molecular and Cellular Neuroscience.

Dendrimeric Aβ1–15 is an effective immunogen in wildtype and APP-tg mice

G. Bitan, C. Lemere, Marcel Maier, 2007, Neurobiology of Aging.

Human cathepsin S: chromosomal localization, gene structure, and tissue distribution.

A. C. Webb, C. Lemere, J. Knoll, 1994, The Journal of biological chemistry.

Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer's disease.

D. Selkoe, H. Weiner, C. Lemere, 2001, DNA and cell biology.

Nasal administration of amyloid‐β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease

D. Selkoe, H. Weiner, C. Lemere, 2000, Annals of neurology.

Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice.

D. Selkoe, H. Weiner, C. Lemere, 2000, Annals of the New York Academy of Sciences.

High-Energy, Whole-Body Proton Irradiation Differentially Alters Long-Term Brain Pathology and Behavior Dependent on Sex and Alzheimer’s Disease Mutations

C. Lemere, M. O’Banion, Jacqueline P. Williams, 2023, International journal of molecular sciences.

Regional distribution of TDP‐43 inclusions in Alzheimer disease (AD) brains: Their relation to AD common pathology

C. Lemere, K. Okamoto, M. Takatama, 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation

D. Selkoe, T. Wisniewski, J. Blusztajn, 1996, Neurobiology of Disease.

Pathological Detection of AB and APP in Brain

C. Lemere, C. Mori, 2004 .

L-3-n-butylphthalide improves cognitive impairment induced by intracerebroventricular infusion of amyloid-beta peptide in rats.

Xiaoliang Wang, C. Lemere, B. Liu, 2009, European journal of pharmacology.

Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice

Rena Li, M. Staufenbiel, C. Lemere, 2007, The Journal of Cell Biology.

Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695

S. Schachter, C. Lemere, Y. Peng, 2007, Neuroscience.

Aducanumab produced a clinically meaningful benefit in association with amyloid lowering

A. Atri, M. Sabbagh, S. Salloway, 2021, Alzheimer's Research & Therapy.

Complement C3 Deficiency Leads to Accelerated Amyloid β Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice

C. Lemere, M. Carroll, Marcel Maier, 2008, The Journal of Neuroscience.

Development of the clinical candidate PBD-C06, a humanized pGlu3-Aβ-specific antibody against Alzheimer’s disease with reduced complement activation

C. Lemere, S. Schilling, J. Rahfeld, 2020, Scientific Reports.

Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain.

P. Lansbury, C. Lemere, W. Zhen, 1999, Journal of medicinal chemistry.

Anti-Amyloid-β Immunotherapy for Alzheimer’s Disease

C. Lemere, H. Crehan, 2016 .

Tau immunization: a cautionary tale?

K. Kosik, D. Walsh, C. Lemere, 2015, Neurobiology of Aging.

Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life

D. Selkoe, E. Masliah, D. Walsh, 2009, Neurobiology of Disease.

The “Nonamyloidogenic” p3 Fragment (Amyloid β17-42) Is a Major Constituent of Down's Syndrome Cerebellar Preamyloid*

H. Wiśniewski, D. Selkoe, M. Lalowski, 1996, The Journal of Biological Chemistry.

Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer’s-like mouse models

C. Lemere, J. Walter, Sathish Kumar, 2020, Acta Neuropathologica Communications.

Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.

C. Cotman, P. S. St George-Hyslop, R. Palmour, 2013, The American journal of pathology.

Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice.

C. Lemere, Sangmook Lee, T. Shea, 2012, Journal of Alzheimer's disease : JAD.

Passive Aβ Immunotherapy: Current Achievements and Future Perspectives

C. Lemere, S. Schilling, J. Rahfeld, 2018, Molecules.

An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice

B. Liu, C. Lemere, S. Schilling, 2015, Neurobiology of Aging.

Immunotherapy for Alzheimer’s disease: hoops and hurdles

C. Lemere, 2013, Molecular Neurodegeneration.

Microglia Do Not Take Up Soluble Amyloid-beta Peptides, But Partially Degrade Them by Secreting Insulin-degrading Enzyme

C. Lemere, Bin Liu, Liangping Li, 2020, Neuroscience.

Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization

W. K. Cullen, R. Anwyl, M. Rowan, 2008, The Journal of Neuroscience.

Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice

Mi-Ae Park, C. Lemere, M. Dicarli, 2020, Alzheimer's Research & Therapy.

Passive Immunization against Pyroglutamate-3 Amyloid-β Reduces Plaque Burden in Alzheimer-Like Transgenic Mice: A Pilot Study

B. Liu, C. Lemere, S. Schilling, 2012, Neurodegenerative Diseases.

Glio-vascular changes during ageing in wild-type and Alzheimer׳s disease-like APP/PS1 mice

C. Lemere, D. Brites, M. Brito, 2015, Brain Research.

Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.

Rena Li, M. Staufenbiel, C. Lemere, 2007, The Journal of cell biology.

Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo

Jung Hoon Jung, M. Rowan, D. Walsh, 2013, Molecular Brain.

Combination of the Glutaminyl Cyclase Inhibitor PQ912 (Varoglutamstat) and the Murine Monoclonal Antibody PBD-C06 (m6) Shows Additive Effects on Brain Aβ Pathology in Transgenic Mice

T. Hoffmann, C. Lemere, S. Schilling, 2021, International journal of molecular sciences.

Focused ultrasound with anti-pGlu3 Aβ enhances efficacy via recruitment of peripheral immune cells.

N. McDannold, C. Lemere, S. Schilling, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Ultrasound-mediated blood-brain barrier disruption improves anti-pyroglutamate3 Aβ antibody efficacy and enhances phagocyte infiltration into brain in aged Alzheimer’s disease-like mice

N. McDannold, C. Lemere, S. Schilling, 2021, bioRxiv.

Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia

T. Mayadas, G. Shankar, C. Lemere, 2012, Glia.

Can Alzheimer disease be prevented by amyloid-β immunotherapy?

E. Masliah, C. Lemere, 2010, Nature Reviews Neurology.

Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.

C. Lemere, Y. Matsuoka, Vicki Olm, 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Rod photoreceptors in infant rats with a history of oxygen exposure.

R. Hansen, A. Fulton, C. Lemere, 1999, Investigative ophthalmology & visual science.

Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response

C. Lemere, C. Janus, P. Das, 2006, The Journal of Neuroscience.

APOE and immunity: Research highlights

Tyler J. Wishard, M. Carrillo, A. Brickman, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Long-Term Sex- and Genotype-Specific Effects of 56Fe Irradiation on Wild-Type and APPswe/PS1dE9 Transgenic Mice

Mi-Ae Park, C. Lemere, M. D. Di Carli, 2021, International journal of molecular sciences.

Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration

C. Lemere, K. Okamoto, M. Takatama, 2009, Neuroscience Letters.

Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?

A. Fagan, K. Mansfield, C. Lemere, 2008, Rejuvenation research.

Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.

D. Selkoe, D. Teplow, C. Lemere, 1995, The Biochemical journal.

Alcohol-induced brain changes in dogs.

L A Hansen, E. Masliah, C. Lemere, 1991, Archives of neurology.

Molecular Neurodegeneration Increased Dj-1 Expression under Oxidative Stress and in Alzheimer's Disease Brains

C. Lemere, M. Goldberg, Jie Shen, 2022 .

Rapid activity-dependent sprouting of optic fibers into a local area denervated by application of beta-bungarotoxin in goldfish tectum.

J. Schmidt, C. Lemere, 1996, Journal of neurobiology.

Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.

J. Trojanowski, V. Lee, D. Mann, 2006, Acta neuropathologica.

Amyloid-β Immunotherapy for Alzheimers Disease

B. Liu, C. Lemere, J. Frost, 2010 .

Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.

C. Lemere, 2009, Progress in brain research.

Alzheimer A beta vaccination of rhesus monkeys (Macaca mulatta).

D. Holtzman, F. Heppner, A. Aguzzi, 2004, Alzheimer disease and associated disorders.

Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans.

C. Lemere, Marcel Maier, T. Seabrook, 2006, Rejuvenation research.

Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer’s Disease

C. Lemere, M. Brito, C. Janota, 2016, Molecular Neurobiology.

A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline.

Jason J. Corneveaux, April N. Allen, D. Bennett, 2012, Human molecular genetics.

A β dimer-containing human cerebrospinal fluid disrupts synaptic plasticity : prevention by systemic passive immunization

W. K. Cullen, R. Anwyl, M. Rowan, 2009 .

Novel Abeta immunogens: is shorter better?

C. Lemere, Marcel Maier, T. Seabrook, 2007, Current Alzheimer Research.

APOE ε4 Association With Cognition and Alzheimer Disease Biomarkers in Down Syndrome-Implications for Clinical Trials and Treatments for All.

D. Holtzman, C. Lemere, E. Head, 2021, JAMA neurology.

Complement C3 Lowering in Adult Inducible Conditional Knockout Mice: Long‐Lasting Effects

C. Lemere, J. Présumey, Shaoming Li, 2022, Alzheimer's & Dementia.

Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains

C. Lemere, Jie Shen, W. Xia, 2009, Molecular Neurodegeneration.

Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice

Mi-Ae Park, C. Lemere, M. Dicarli, 2020, Alzheimer's Research & Therapy.

Alzheimer Aβ Vaccination of Rhesus Monkeys (Macaca Mulatta)

D. Holtzman, F. Heppner, A. Aguzzi, 2004 .

Can Alzheimer disease be prevented by amyloid-β immunotherapy?

E. Masliah, C. Lemere, Eliezer Masliah, 2010, Nature Reviews Neurology.

Alzheimer’s Aβ vaccination of rhesus monkeys (Macaca mulatta)

D. Holtzman, F. Heppner, A. Aguzzi, 2004, Mechanisms of Ageing and Development.

ARE ANTI-ABETA AGGREGATE-PREFERRING ANTIBODIES THE FUTURE FOR AD IMMUNOTHERAPY?

C. R. Vanderburgh, D. Walsh, C. Lemere, 2014, Alzheimer's & Dementia.

CEREBRAL CORTICAL ABNORMALITIES IN AIDS: 269

G. Press, E. Masliah, C. Lemere, 1990 .

Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta).

D. Holtzman, F. Heppner, A. Aguzzi, 2004, Mechanisms of ageing and development.

Complement and microglia mediate early synapse loss in Alzheimer mouse models

D. Selkoe, B. Barres, C. Lemere, 2016, Science.

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shaomin Li, M. Rowan, B. Sabatini, 2008, Nature Medicine.

Amyloid-beta immunotherapy for Alzheimer's disease.

C. Lemere, J. Frost, B. Liu, 2010, CNS & neurological disorders drug targets.

Regional distribution of TDP‐43 inclusions in Alzheimer disease (AD) brains: Their relation to AD common pathology

C. Lemere, K. Okamoto, M. Takatama, 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

The Importance of Complement-Mediated Immune Signaling in Alzheimer’s Disease Pathogenesis

C. Lemere, Khyrul Khan, André F. Batista, 2024, International journal of molecular sciences.

Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.

C. Lemere, Y. Matsuoka, Vicki Olm, 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.